메뉴 건너뛰기




Volumn 24, Issue 2, 2016, Pages 82-84

Strength in Diversity: Hidden Genetic Depths of Mycobacterium tuberculosis

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; TUBERCULOSTATIC AGENT;

EID: 84959113154     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2015.12.006     Document Type: Short Survey
Times cited : (3)

References (7)
  • 1
  • 2
    • 84949032318 scopus 로고    scopus 로고
    • Diversity of Mycobacterium tuberculosis across evolutionary scales
    • O'Neill M.B., et al. Diversity of Mycobacterium tuberculosis across evolutionary scales. PLoS Pathog. 2015, 11:e1005257.
    • (2015) PLoS Pathog. , vol.11 , pp. e1005257
    • O'Neill, M.B.1
  • 3
    • 84945118021 scopus 로고    scopus 로고
    • Whole genome sequencing reveals genomic heterogeneity and antibiotic purification in Mycobacterium tuberculosis isolates
    • Black P.A., et al. Whole genome sequencing reveals genomic heterogeneity and antibiotic purification in Mycobacterium tuberculosis isolates. BMC Genomics 2015, 16:857.
    • (2015) BMC Genomics , vol.16 , pp. 857
    • Black, P.A.1
  • 4
    • 84869066832 scopus 로고    scopus 로고
    • Dynamic population changes in Mycobacterium tuberculosis during acquisition and fixation of drug resistance in patients
    • Sun G., et al. Dynamic population changes in Mycobacterium tuberculosis during acquisition and fixation of drug resistance in patients. J. Infect. Dis. 2012, 206:1724-1733.
    • (2012) J. Infect. Dis. , vol.206 , pp. 1724-1733
    • Sun, G.1
  • 5
    • 84903885450 scopus 로고    scopus 로고
    • Evolution of drug resistance in tuberculosis: recent progress and implications for diagnosis and therapy
    • Trauner A., et al. Evolution of drug resistance in tuberculosis: recent progress and implications for diagnosis and therapy. Drugs 2014, 74:1063-1072.
    • (2014) Drugs , vol.74 , pp. 1063-1072
    • Trauner, A.1
  • 6
    • 79955460244 scopus 로고    scopus 로고
    • Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection
    • Ford C.B., et al. Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection. Nat. Genet. 2011, 43:482-486.
    • (2011) Nat. Genet. , vol.43 , pp. 482-486
    • Ford, C.B.1
  • 7
    • 84949194114 scopus 로고    scopus 로고
    • Within patient microevolution of Mycobacterium tuberculosis correlates with heterogeneous responses to treatment
    • Liu Q., et al. Within patient microevolution of Mycobacterium tuberculosis correlates with heterogeneous responses to treatment. Sci. Rep. 2015, 5:17507.
    • (2015) Sci. Rep. , vol.5 , pp. 17507
    • Liu, Q.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.